US Patent 11359018 Anti-PD-1 antibodies and compositions
Patent 11359018 was granted and assigned to Symphogen on June, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Camilla Frohlich0
Gunther Roland Galler0
Johan Lantto0
Klaus Koefoed0
Monika Gad0
Thomas Bouquin0
Torben Gjetting0
Vikram Kjoller Bhatia0
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113590180
Date of Patent
June 14, 2022
0Patent Application Number
164619570
Date Filed
November 17, 2017
0Patent Citations
Patent Primary Examiner
CPC Code
Edits on 22 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+13 properties)
Article (+147 characters)
US Patent 11359018 Anti-PD-1 antibodies and compositions
Article
This invention relates to anti-PD-1 antibodies and methods of using them in treating diseases and conditions related to PD-lactivity, e.g., cancer.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11359018
Date of patent
June 14, 2022
Patent application number
16461957
Date Filed
November 17, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 11359018 Anti-PD-1 antibodies and compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.